China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) EV-to-EBIT

China Shineway Pharmaceutical Group Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT							3.01	0.39	0.64	0.63	-0.05

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT																0.64	-	0.63	-	-

For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Shineway Pharmaceutical Group's EV-to-EBIT falls into.

China Shineway Pharmaceutical Group EV-to-EBIT Calculation

China Shineway Pharmaceutical Group's EV-to-EBIT for today is calculated as:

China Shineway Pharmaceutical Group's current Enterprise Value is $267.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Shineway Pharmaceutical Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $173.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group  (OTCPK:CSWYY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

China Shineway Pharmaceutical Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

China Shineway Pharmaceutical Group's Enterprise Value for the quarter that ended in Jun. 2023 was $70.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Shineway Pharmaceutical Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $173.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Shineway Pharmaceutical Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description